Albany, NY, United States of America

Heidi Schlager

This inventor holds 1 USPTO granted patent. Top assignee: Pharmapotheca a, Inc.. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Heidi Schlager

Introduction

Heidi Schlager is a notable inventor based in Albany, NY (US). She has made significant contributions to the field of chemistry, particularly in the manufacturing of high-purity amphetamines. Her innovative approach has garnered attention in the scientific community.

Latest Patents

Heidi Schlager holds a patent for a non-distillative process for manufacturing high purity amphetamines. This invention provides a method for obtaining a highly pure phosphoramidate compound, which is then converted into an amphetamine sulfate compound. The process involves concentrating the amphetamine sulfate compound in isopropanol and salting out the amphetamine compound directly to obtain various amphetamine salts, including amphetamine saccharate, amphetamine sulfate, and others.

Career Highlights

Heidi has dedicated her career to advancing chemical processes and improving the purity of pharmaceutical compounds. Her work has implications for both medical and recreational uses of amphetamines, showcasing her expertise in the field.

Collaborations

Heidi collaborates with her coworker, Darryl Cleary, to further enhance their research and development efforts at Pharmapotheca, Inc. Their teamwork exemplifies the importance of collaboration in scientific innovation.

Conclusion

Heidi Schlager's contributions to the field of chemistry through her innovative patent demonstrate her commitment to advancing pharmaceutical manufacturing processes. Her work continues to influence the industry and highlights the importance of innovation in science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…